Biogen Plans to Initiate Phase 4 Study Evaluating Benefit of SPINRAZA® (nusinersen) in Patients Treated with Zolgensma® (onasemnogene abeparvovec)
In the long-term follow-up study of Zolgensma® and real-world experience, it has been reported that some patients previously treated with […]